Rheumatology leaders and patients go to Capitol Hill to advocate

September 10, 2019

WASHINGTON, DC - Physicians and health professionals from the American College of Rheumatology (ACR) along with rheumatology patients gathered on Capitol Hill this week for the annual Advocates for Arthritis event to urge lawmakers to take action on a range of policy issues affecting patient access to rheumatology care.  

More than 100 advocates met with members of Congress and encouraged them to support bills that would expand the rheumatology workforce and reform insurer practices that often delay patients' access to medically necessary treatment. Advocates also educated lawmakers on the increasing prevalence of rheumatic diseases, specifically arthritis, that are exacting a toll on Americans of all ages and backgrounds.

"Aligning with Rheumatic Disease Awareness Month, this event is a great opportunity for our members to raise awareness and work with lawmakers to address the myriad challenges rheumatic disease patients currently face," said Paula Marchetta, MD, MBA, president of ACR. "We look forward to working with Congress to make positive and lasting policy changes so that patients can live longer, healthier, and more fulfilling lives."

ACR advocates asked lawmakers to support the following legislation to improve patient access to care: An estimated 1 in 4 Americans have been diagnosed with a rheumatic disease such as osteoarthritis, rheumatoid arthritis, and lupus. Although there is no known cure for these conditions, early intervention and proper diagnosis and treatment by a specialist can help patients manage symptoms and lifestyle limitations to live longer, healthier lives. 

Unfortunately, a growing shortage of rheumatology specialists threatens patient access to timely diagnosis and treatment. For example, although nearly 300,000 American children have juvenile arthritis, there are fewer than 400 board-certified pediatric rheumatologists in the United States.

Jocelyn Givens
jgivens@rheumatology.org
404-929-4810
-end-
The American College of Rheumatology (ACR) is the nation's leading medical association for the rheumatology community and represents more than 7,700 U.S. rheumatologists and rheumatology health professionals. As an ethically driven, professional membership organization, the ACR is committed to improving healthcare for Americans living with rheumatic diseases and advocates for policies and reforms that will ensure safe, effective, affordable and accessible rheumatology care.

American College of Rheumatology

Related Rheumatology Articles from Brightsurf:

61 healthcare groups urge Congress to support implementing the physician fee schedule
Today, more than 60 healthcare stakeholders, representing Medicare providers, signed a letter urging congressional leaders to support bipartisan legislation that would implement the Centers for Medicare and Medicaid Service's (CMS) Calendar Year 2021 Medicare Physician Fee Schedule (MPFS) final rule as written.

New RA guideline emphasizes maximizing methotrexate and biologics, minimizing steroids
The American College of Rheumatology (ACR) will preview its 2020 Guideline for the Management of Rheumatoid Arthritis (RA) at ACR Convergence, the ACR's annual meeting.

Different outcomes by race/ethnicity among patients with COVID-19 and rheumatic disease
Among US patients with rheumatic disease and COVID-19, racial/ethnic minorities had higher risks of needing to be hospitalized and put on ventilators.

Lockdown impact: Worsening symptoms for people with bone, joint and muscle pain
A new study reveals the impact of lockdown for people with bone, joint and muscle pain.

Improving the transition from pediatric to adult rheumatology care
As children with chronic rheumatic illnesses age, it's important that they experience a smooth transition from pediatric to adult care.

The Lancet Rheumatology: Small observational study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements
The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm [1] in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27 March 2020) in a Milan hospital, published in The Lancet Rheumatology journal.

Nerve stimulation may benefit women with fibromyalgia
Published in Arthritis & Rheumatology, a treatment involving electrical nerve stimulation helped women with fibromyalgia in a recent clinical trial.

ACR and EULAR release new classification criteria for IgG4-related disease
The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) released the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease.

370 healthcare groups send letter to congress urging prior authorization reform in medicare advantage
The American College of Rheumatology (ACR), along with 369 other leading patient, physician, and healthcare professional organizations, sent a letter to Congress urging passage of the Improving Seniors' Timely Access to Care Act of 2019 (H.R.

Rheumatology leaders and patients go to Capitol Hill to advocate
Physicians and health professionals from the American College of Rheumatology (ACR) along with rheumatology patients gathered on Capitol Hill this week for the annual Advocates for Arthritis event to urge lawmakers to take action on a range of policy issues affecting patient access to rheumatology care.

Read More: Rheumatology News and Rheumatology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.